Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nozomi Akanuma is active.

Publication


Featured researches published by Nozomi Akanuma.


Neurochemistry International | 1999

Differential effects of acute and chronic treatment with typical and atypical neuroleptics on c-fos mRNA expression in rat forebrain regions using non-radioactive in situ hybridization

Jun’ichi Semba; Maki Wakuta Sakai; Tetsuya Suhara; Nozomi Akanuma

The regional difference in the expression of c-fos mRNA in rat forebrain after either acute or chronic administration of typical (haloperidol and fluphenazine) and atypical neuroleptics (clozapine and (+/-)-sulpiride) was investigated. Rats were injected intraperitoneally with vehicle or neuroleptics daily for 14 days. Twenty-four hours after the last injection, the rats were challenged with vehicle or neuroleptics. C-fos mRNA expression was determined by non-radioactive in situ hybridization. Acute treatment with typical neuroleptics induced a remarkable induction of c-fos mRNA in the dorsolateral striatum, whereas this induction was greatly attenuated by chronic administration. All neuroleptics examined induced c-fos mRNA in the shell region of N. accumbens by acute administration and this expression was still elevated after chronic treatment. Since chronic neuroleptics do not induce tolerance to their antipsychotic activities, our study suggests that the shell region of N. accumbens is an important target site for antipsychotic effects of neuroleptics.


Neuroscience Research | 2000

Chronic lithium chloride injection increases glucocorticoid receptor but not mineralocorticoid receptor mRNA expression in rat brain.

Jun'ichi Semba; Hideei Watanabe; Tetsuya Suhara; Nozomi Akanuma

Lithium has been used clinically for the treatment of bipolar disorders. However, the brain mechanisms, by which lithium acts, are still unclear. An impaired hypothalamic-pituitary-adrenal (HPA) axis has been implicated in the pathogenesis of mood disorders. In this study, we investigated the effects of chronic lithium on the corticosteroid receptors in the brain. Male Wistar rats were injected with LiCl (1.5 mEq/kg) or saline intraperitoneally (i.p.) once a day for 14 days. Twenty-four hours after the last injection, the expressions of mRNA for glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) in the brain were determined by non-radioactive in situ hybridization. Chronic administration of LiCl increased the expression of GR mRNA in the hippocampus and paraventricular nucleus of the hypothalamus (PVN). However, no significant changes were observed in the expression of either MR mRNA in the hippocampus or GR mRNA in the locus ceruleus. Since the hippocampus and PVN mediate negative feedback regulation of the HPA axis, an increased expression of GR mRNA in these regions may normalize HPA axis activity in mood disorders. Thus, the effect of chronic lithium on GR function may be involved in its antimanic and/or prophylactic activity in bipolar disorders.


Progress in Neuro-psychopharmacology & Biological Psychiatry | 2000

Neonatal treatment with L-name (NG-nitro-L-arginine methyl ester) attenuates stereotyped behavior induced by acute methamphetamine but not development of behavioral sensitization to methamphetamine.

Jun'ichi Semba; Hideei Watanabe; Tetsuya Suhara; Nozomi Akanuma

1. The neurodevelopmental hypothesis of schizophrenia postulates that disturbed nitric oxide (NO) function during neuronal development is one of premorbid factors for schizophrenia in later life. 2. The aim of present study is to investigate behaviorally whether neonatal inhibition of nitric oxide synthase (NOS) affects dopaminergic function, the abnormality of which may be ascribed to a major pathophysiology of schizophrenia. 3. Male rat pups were injected daily with NOS inhibitor, NG-nitro-L-arginine methyl ester (L-NAME), from postnatal day (PD) 1 to 14. 4. When methamphetamine (MAP) was challenged on PD42, MAP-induced stereotypy was significantly attenuated in the L-NAME treated rats. The development of sensitization to the stereotypy-inducing effect of MAP, however, was not prevented with neonatal L-NAME. 5. These results suggest that decreased NO production during neonatal period may disturb normal maturation of dopaminergic system and result in impaired dopaminergic function in adult period.


Neuroscience Research | 1997

2905 Effects of acute and chronic treatment of haloperidol, clozapine and sulpiride on c-fos mRNA expression in rat forebrain regions

Jun'ichi Semba; Maki Wakuta Sakai; Nozomi Akanuma

FUMIO SHIMA, KATSUYA ISHIDO, MOTOHIRO KATO Freezing of gait in the patients with Parkinson’s disease (PD) is caused by damage of the structures essential for movements that are self-initiated, and self-guided, and it is well corrected by exteroceptive guidance as known as “paradoxical kinesia” . Posteroventral pallidotomy (PVP) alleviates dramatically bradykinesia, however, it often fails to improve the initial hesitation of gait. Sbjecting the PD patients with marked freezing and minimum signs of bradykinesia and rigidity, we made unilateral stimulation of the internal pallidum (GPi) giving high frequency pulses (120Hz, 0.2~s, l-2V). The deep stimulation therapy (DBS) improved dramatically the locomotion problems in most cases. Effective zone of DBS located anterodorsally to PVP region may connect to the supplementary motor area (SMA) via the thalamic nucleus, and high frequency stimulation of the pallidal zone elliminates freezing by activating the SMA bilaterally.


Molecular Brain Research | 2004

Alterations in the expressions of mRNA for GDNF and its receptors in the ventral midbrain of rats exposed to subchronic phencyclidine

Jun'ichi Semba; Nozomi Akanuma; Maki Wakuta; Noriko Tanaka; Tetsuya Suhara


Comprehensive Psychiatry | 2006

Déjà vu experiences in patients with schizophrenia

Takuya Adachi; Naoto Adachi; Yoshikazu Takekawa; Nozomi Akanuma; Masumi Ito; Ryouji Matsubara; Hiroshi Ikeda; Michihiro Kimura; Heii Arai


Comprehensive Psychiatry | 2007

Déjà vu experiences in schizophrenia : relations with psychopathology and antipsychotic medication

Naoto Adachi; Takuya Adachi; Nozomi Akanuma; Ryouji Matsubara; Masumi Ito; Yoshikazu Takekawa; Hiroshi Ikeda; Heii Arai


Archive | 2015

Dissociativeexperiencesinepilepsy:Effectsofepilepsy-relatedfactorson pathological dissociation

Koichiro Hara; Nozomi Akanuma; M asumi Ito; M itsutoshi Okazaki; Ryoji Matsubara; Takuya Adachi; Masaaki Kato; Teiichi Onuma


Archive | 2010

Epileptic, organic and genetic vulnerabilities for timing of the development of interictal

Nozomi Akanuma; Masumi Ito; Masaaki Kato; Tsunekatsu Hara; Yasunori Oana; Masato Matsuura; Yoshiro Okubo; Teiichi Onuma


Archive | 2008

Brief Communication Psychiatric comorbidity in adult patients with idiopathic generalized epilepsy

Nozomi Akanuma; Eriko Hara; Naoto Adachi; Koichiro Hara; Michael Koutroumanidis

Collaboration


Dive into the Nozomi Akanuma's collaboration.

Top Co-Authors

Avatar

Jun'ichi Semba

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Tetsuya Suhara

National Institute of Radiological Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hiroshi Ikeda

Sapporo Medical University

View shared research outputs
Top Co-Authors

Avatar

Koichiro Hara

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Naoto Adachi

University of Cambridge

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge